FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048285910> ?p ?o ?g. }

• W3048285910 endingPage "11082" @default.
• W3048285910 startingPage "11067" @default.
• W3048285910 abstract "Natural killer (NK) cell-based immunotherapy represents a promising strategy to overcome the bottlenecks of cancer treatment. However, the therapeutic efficacy is greatly limited by downregulation of recognition ligands on the tumor cell surface, and the immunosuppressive effects can be thwarted by the tumor microenvironment such as secretion of transforming growth factor-beta (TGF-β), which could stunt the NK cell-mediated immune response. To overcome these limitations, herein we developed a nanoemulsion system (SSB NMs) to co-deliver TGF-β inhibitor and selenocysteine (SeC) to achieve amplified anticancer efficacy. SSB NMs significantly enhanced the lytic potency of NK92 cells by 2.1-fold. Moreover, a subtoxic dose of SSB NMs effectively sensitized MDA-MB-231 triple-negative breast cancer (TNBC) cells to NK cells derived from seven clinical patients, resulting in an up to 13.8-fold increase in cancer lysis. Mechanistic studies reveal that the sensitizing effects relied on natural killer group 2, member D (NKG2D)/NKG2D ligands (NKG2DLs) signaling with the involvement of DNA damage response. SSB NMs also effectively restrained TGF-β/TGF-β RI/Smad2/3 signaling, which thus enhanced NKG2DL expression on tumor cells and stimulated NKG2D surface expression on NK92 cells, ultimately contributing to the enhanced immune response. Furthermore, SSB NMs sustained release of SeC and TGF-β inhibitor and synergized with NK92 cells to induce significant anticancer effects in vivo. Together, this study not only demonstrates a simple strategy for the design of a nanoemulsion to co-deliver synergistic drugs but also sheds light on the application and action mechanisms in NK cell adaptive therapy against breast cancer, especially TNBCs." @default.
• W3048285910 created "2020-08-13" @default.
• W3048285910 creator A5023178674 @default.
• W3048285910 creator A5073814784 @default.
• W3048285910 creator A5085565321 @default.
• W3048285910 date "2020-08-07" @default.
• W3048285910 modified "2023-10-18" @default.
• W3048285910 title "Boosting Natural Killer Cell-Based Cancer Immunotherapy with Selenocystine/Transforming Growth Factor-Beta Inhibitor-Encapsulated Nanoemulsion" @default.
• W3048285910 cites W1159619803 @default.
• W3048285910 cites W1587153999 @default.
• W3048285910 cites W1599718730 @default.
• W3048285910 cites W1828863062 @default.
• W3048285910 cites W1970195787 @default.
• W3048285910 cites W2000581595 @default.
• W3048285910 cites W2003690177 @default.
• W3048285910 cites W2020914260 @default.
• W3048285910 cites W2023283620 @default.
• W3048285910 cites W2038773467 @default.
• W3048285910 cites W2060070314 @default.
• W3048285910 cites W2061827331 @default.
• W3048285910 cites W2064718707 @default.
• W3048285910 cites W2068688852 @default.
• W3048285910 cites W2087709616 @default.
• W3048285910 cites W2093009509 @default.
• W3048285910 cites W2099987999 @default.
• W3048285910 cites W2104882286 @default.
• W3048285910 cites W2142548447 @default.
• W3048285910 cites W2150319141 @default.
• W3048285910 cites W2260497117 @default.
• W3048285910 cites W2287383446 @default.
• W3048285910 cites W2288359973 @default.
• W3048285910 cites W2294976193 @default.
• W3048285910 cites W2298503769 @default.
• W3048285910 cites W2311158642 @default.
• W3048285910 cites W2528086526 @default.
• W3048285910 cites W2550677391 @default.
• W3048285910 cites W2570763587 @default.
• W3048285910 cites W2581996160 @default.
• W3048285910 cites W2599931180 @default.
• W3048285910 cites W2611532324 @default.
• W3048285910 cites W2615682320 @default.
• W3048285910 cites W2742105486 @default.
• W3048285910 cites W2747016053 @default.
• W3048285910 cites W2748446253 @default.
• W3048285910 cites W2767867771 @default.
• W3048285910 cites W2775177930 @default.
• W3048285910 cites W2775756496 @default.
• W3048285910 cites W2778089192 @default.
• W3048285910 cites W2785803176 @default.
• W3048285910 cites W2788975052 @default.
• W3048285910 cites W2791998350 @default.
• W3048285910 cites W2808996934 @default.
• W3048285910 cites W2886414470 @default.
• W3048285910 cites W2889290358 @default.
• W3048285910 cites W2890359689 @default.
• W3048285910 cites W2909660453 @default.
• W3048285910 cites W2914757005 @default.
• W3048285910 cites W2918950605 @default.
• W3048285910 cites W2920256884 @default.
• W3048285910 cites W2936108057 @default.
• W3048285910 cites W2964257368 @default.
• W3048285910 cites W2964928928 @default.
• W3048285910 cites W2968418725 @default.
• W3048285910 cites W2971991240 @default.
• W3048285910 cites W2998314570 @default.
• W3048285910 cites W4243419013 @default.
• W3048285910 doi "https://doi.org/10.1021/acsnano.9b10103" @default.
• W3048285910 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32806028" @default.
• W3048285910 hasPublicationYear "2020" @default.
• W3048285910 type Work @default.
• W3048285910 sameAs 3048285910 @default.
• W3048285910 citedByCount "56" @default.
• W3048285910 countsByYear W30482859102021 @default.
• W3048285910 countsByYear W30482859102022 @default.
• W3048285910 countsByYear W30482859102023 @default.
• W3048285910 crossrefType "journal-article" @default.
• W3048285910 hasAuthorship W3048285910A5023178674 @default.
• W3048285910 hasAuthorship W3048285910A5073814784 @default.
• W3048285910 hasAuthorship W3048285910A5085565321 @default.
• W3048285910 hasConcept C109316439 @default.
• W3048285910 hasConcept C121608353 @default.
• W3048285910 hasConcept C185592680 @default.
• W3048285910 hasConcept C202751555 @default.
• W3048285910 hasConcept C203014093 @default.
• W3048285910 hasConcept C2776107976 @default.
• W3048285910 hasConcept C2777701055 @default.
• W3048285910 hasConcept C2778102761 @default.
• W3048285910 hasConcept C2778867473 @default.
• W3048285910 hasConcept C2780674031 @default.
• W3048285910 hasConcept C502942594 @default.
• W3048285910 hasConcept C54355233 @default.
• W3048285910 hasConcept C55493867 @default.
• W3048285910 hasConcept C86803240 @default.
• W3048285910 hasConcept C8891405 @default.
• W3048285910 hasConcept C96232424 @default.
• W3048285910 hasConceptScore W3048285910C109316439 @default.
• W3048285910 hasConceptScore W3048285910C121608353 @default.
• W3048285910 hasConceptScore W3048285910C185592680 @default.

• next